Summary of the actual WHO experiencing on the growth and development of productspecific reference point supplies with regard to coagulation factor VIII and also factor IX products: Revision history

Jump to: navigation, search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

27 November 2023

  • curprev 05:2205:22, 27 November 2023‎ 66.90.114.182 talk‎ 3,504 bytes +3,504‎ Created page with "We all integrated 648 COVID-19-positive patients which has a mean ages of 24 decades. Of such, 11.9% were from the essential group. Risk factors connected with a whole lot worse final results provided adult males (OR=1.Ninety two), get older >60 years (OR=3.Sixty five), heart illnesses (OR=3.05), continual respiratory system illnesses (OR=2.30), as well as situations with several comorbidities (OR=2.Fifty-seven) after changing regarding age and sex; all had significan..."
Retrieved from "https://news.npo.digital/index.php?title=Summary_of_the_actual_WHO_experiencing_on_the_growth_and_development_of_productspecific_reference_point_supplies_with_regard_to_coagulation_factor_VIII_and_also_factor_IX_products"